Core Scientific (CORZ) Revenue (2021 - 2026)

Core Scientific has disclosed Revenue across 6 years of filings, most recently posting $164.2 million for Q2 2026.

• In Q2 2026, Revenue rose 108.83% year-over-year to $164.2 million; the TTM figure through Jun 2026 stood at $440.3 million (up 26.37% YoY), while the FY2025 annual figure was $319.0 million, down 37.53% from the prior year.
• Revenue came in at $164.2 million for Q2 2026 at Core Scientific, up from $115.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $192.5 million in Q1 2022 to a low of $78.6 million in Q2 2025.
• Average Revenue over 5 years is $125.1 million, with a median of $121.0 million recorded in 2022.
• The largest YoY upside for Revenue was 254.9% in 2022 against a maximum downside of 59.82% in 2022.
• Over 5 years, Revenue stood at $121.2 million in 2022, then increased by 17.05% to $141.9 million in 2023, then slumped by 33.12% to $94.9 million in 2024, then retreated by 15.97% to $79.8 million in 2025, then jumped by 105.86% to $164.2 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $164.2 million in Q2 2026, $115.2 million in Q1 2026, and $79.8 million in Q4 2025.